Synapse - Gary Schwartz

Results (385)

Inhibition of MDM2 by nutlin induces apoptosis in response to DNA damage in cells with mutant p53 in an E2F1-dependent manner

Meeting Abstract

Ambrosini, G.; Sambol, E.; Maki, R.; Vassilev, L.; Singer, S.; Schwartz, G. K.
Cancer Research (2005)

Fulltext@MSK | Save

A multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Meeting Abstract

Shah, M. A.; Ilson, D.; Ramanathan, R. K.; Levner, A.; D'adamo, D.; Schwartz, L.; Casper, E.; Schwartz, G. K.; Kelsen, D. P.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

A randomized phase II trial comparing two paclitaxel (P)-cisplatin (C) containing chemoradiation (CRT) regimens as adjuvant therapy in resected gastric cancer (RTOG Intergroup #0114)

Meeting Abstract

Schwartz, G. K.; Winter, K.; Minsky, B.; Janjan, N.; Schaefer, P.; Thomson, J.; Rani, A.; Gross, H.; Willett, C.; Kelsen, D.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Flavopiridol monotherapy has antiproliferative activity in a panel of soft tissue sarcoma cell lines as well as in vivo antitumor efficacy

Meeting Abstract

Sambol, E. B.; Kennealey, P. T.; Motwani, M.; She, Y.; Geha, R. C.; O'Connor, R.; Schwartz, G. K.; Singer, S.
Annals of Surgical Oncology (2005)

Fulltext@MSK | Save

A phase I clinical and pharmacokinetic study of weekly docetaxel followed by flavopiridol: Promising activity in metastatic pancreatic cancer

Meeting Abstract

Rathkopf, D.; Fornier, M.; Shah, M. A.; Kortmansky, J.; O'reilly, E.; Winkelmann, J.; Balzano, L.; Kelsen, D. P.; Schwartz, G. K.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer

Meeting Abstract

Kortmansky, J. S.; O'Reilly, E. M.; Minsky, B. D.; Puleio, S. A.; Winkelmann, J.; Kelsen, D. P.; Schwartz, G. K.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

NMR detectable cholesterol is an early marker of tumor response to cytotoxic chemotherapy in colon cancer xenografts

Meeting Abstract

Kennealey, P. T.; Sambol, E. B.; Decarolis, P.; Geha, R. C.; She, Y. H.; Schwartz, G. K.; Chen, J. H.; Singer, S.
Journal of the American College of Surgeons (2005)

Fulltext@MSK | Save

Cyclin-dependent kinases as targets for cancer therapy

Journal Article

Shah, M. A.; Schwartz, G. K.
Cancer Chemotherapy and Biological Response Modifiers (2005)

Fulltext@MSK | Save

A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol

Journal Article

Shah, M. A.; Kortmansky, J.; Motwani, M.; Drobnjak, M.; Gonen, M.; Yi, S.; Weyerbacher, A.; Cordon-Cardo, C.; Lefkowitz, R.; Brenner, B.; more...
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Drg1 expression in 131 colorectal liver metastases: Correlation with clinical variables and patient outcomes

Journal Article

Shah, M. A.; Kemeny, N.; Hummer, A.; Drobnjak, M.; Motwani, M.; Cordon-Cardo, C.; Gonen, M.; Schwartz, G. K.
Clinical Cancer Research (2005)

Fulltext@MSK | Save